Healthcare & Life Sciences
NXI Therapeutics
Switzerlandnxitherapeutics.com
NXI Therapeutics is a Healthcare & Life Sciences startup based in Switzerland, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About NXI Therapeutics
NXI Therapeutics is a company headquartered in Switzerland. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
NXI Therapeutics develops selective immunosuppressive drugs targeting coronin 1 to treat autoimmune diseases and organ transplant rejection, aiming to improve efficacy and safety by avoiding the adverse effects of conventional immunosuppressants.
Explore NXI Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.